AU2003262922A1 - Retroductal salivary gland genetic vaccination - Google Patents

Retroductal salivary gland genetic vaccination

Info

Publication number: AU2003262922A1
Authority: AU; Australia
Prior art keywords: retroductal; salivary gland; genetic vaccination; vaccination; genetic
Prior art date: 2002-08-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003262922A

Other versions

AU2003262922A8 (en

Inventor

Michael Bennett

Yen-Ju Chen

David Olson

Sean Tucker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genteric Inc

Original Assignee

Genteric Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-30

Filing date

2003-08-26

Publication date

2004-03-19

2003-08-26 Application filed by Genteric Inc filed Critical Genteric Inc

2004-03-19 Publication of AU2003262922A8 publication Critical patent/AU2003262922A8/en

2004-03-19 Publication of AU2003262922A1 publication Critical patent/AU2003262922A1/en

Status Abandoned legal-status Critical Current

Links

238000011239 genetic vaccination Methods 0.000 title 1
210000003079 salivary gland Anatomy 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003262922A 2002-08-30 2003-08-26 Retroductal salivary gland genetic vaccination Abandoned AU2003262922A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US40737502P	2002-08-30	2002-08-30
US60/407,375		2002-08-30
US45399903P	2003-03-11	2003-03-11
US60/453,999		2003-03-11
US63993503A	2003-08-12	2003-08-12
US10/639,935		2003-08-12
PCT/US2003/026872 WO2004020592A2 (en)	2002-08-30	2003-08-26	Retroductal salivary gland genetic vaccination

Publications (2)

Publication Number	Publication Date
AU2003262922A8 AU2003262922A8 (en)	2004-03-19
AU2003262922A1 true AU2003262922A1 (en)	2004-03-19

Family

ID=31982347

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003262922A Abandoned AU2003262922A1 (en)	2002-08-30	2003-08-26	Retroductal salivary gland genetic vaccination

Country Status (2)

Country	Link
AU (1)	AU2003262922A1 (en)
WO (1)	WO2004020592A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2477652B1 (en)	2009-09-16	2015-04-15	Vaxart, Inc.	Immunization strategy to prevent h1n1 infection
DK3107568T3 (en)	2014-02-20	2024-06-03	Vaxart Inc	Formulations for administration to the small intestine
ES2832504T3 (en)	2015-06-12	2021-06-10	Vaxart Inc	Formulations for administration of norovirus and rsv antigens in the small intestine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5593972A (en) *	1993-01-26	1997-01-14	The Wistar Institute	Genetic immunization
US5885971A (en) *	1995-03-24	1999-03-23	The Regents Of The University Of California	Gene therapy by secretory gland expression
US5744460A (en) *	1996-03-07	1998-04-28	Novartis Corporation	Combination for treatment of proliferative diseases
US5962429A (en) *	1996-11-22	1999-10-05	University Of Iowa	Complexes of adenovirus with cationic molecules
US6372722B1 (en) *	2000-01-19	2002-04-16	Genteric, Inc.	Method for nucleic acid transfection of cells

2003
- 2003-08-26 WO PCT/US2003/026872 patent/WO2004020592A2/en not_active Application Discontinuation
- 2003-08-26 AU AU2003262922A patent/AU2003262922A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004020592A3 (en)	2004-08-12
WO2004020592A2 (en)	2004-03-11
AU2003262922A8 (en)	2004-03-19

Legal Events

Date	Code	Title	Description
2005-06-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
AU2003231251A1 (en)	2003-11-17	Ferrule assembly
AU2003243715A1 (en)	2004-03-29	Thermal interface materials
AUPS323102A0 (en)	2002-07-18	Removable tile spacer
AU2003258005A1 (en)	2004-04-08	Deadblow hammer
AU2002322059A1 (en)	2002-12-23	Improved vaccination against anthrax
AU2003285320A1 (en)	2004-06-07	Vaccine
AU2003263849A1 (en)	2004-03-11	Gace spacer
AU2003301316A1 (en)	2004-05-04	Improved immunotherapy
AU2003272301A1 (en)	2004-03-29	Carotene-specific lipase
AU2003234955A1 (en)	2003-12-31	Micromanipulator
AU2003285525A1 (en)	2004-06-18	Building
AU2003273035A1 (en)	2004-05-04	Gene vaccine
AU2003262922A1 (en)	2004-03-19	Retroductal salivary gland genetic vaccination
AU2002254161A1 (en)	2002-09-24	M cell directed vaccines
AU2003237701A1 (en)	2003-12-12	Vaccines
AU2003256785A1 (en)	2004-02-16	Improved shears
AU2003294705A1 (en)	2004-06-07	NtSM GENE
AU2003297059A1 (en)	2004-07-09	Chip-in-a-well scanning
EP1595127A3 (en)	2005-11-10	Chip-in-a-well scanning
AU2003223816A1 (en)	2003-12-12	Framework construction
AU2003221776A1 (en)	2003-12-02	Electroporation-mediated transfection of the salivary gland
AU2002347346A1 (en)	2003-06-17	Dna vaccine
AU2003205657A1 (en)	2003-09-16	Spacer
AU2003251054A1 (en)	2004-03-03	Buildings
AU2003275545A1 (en)	2004-05-04	Staple case